Compare Stocks: GCTK, ICCM, HSCS, and INBS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GCTK GlucoTrack	$0.34 -2.4%	$0.39	$0.25 ▼ $14.14	$2.62M	0.7	6.33 million shs	50,984 shs
HSCS HeartSciences	$2.91 +3.8%	$2.39	$1.63 ▼ $3.80	$11.10M	1.79	908,368 shs	263,078 shs
ICCM IceCure Medical	$2.24 -7.9%	$3.90	$2.12 ▼ $42.00	$7.79M	0.47	1.31 million shs	481,421 shs
INBS Intelligent Bio Solutions	$2.35 -6.4%	$2.19	$1.52 ▼ $24.90	$6.95M	4.21	318,799 shs	35,073 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GCTK GlucoTrack	0.00%	-5.44%	+19.30%	-30.52%	-93.72%
HSCS HeartSciences	0.00%	+35.92%	+17.15%	+41.41%	-23.29%
ICCM IceCure Medical	0.00%	-19.54%	-21.10%	-65.53%	-90.82%
INBS Intelligent Bio Solutions	0.00%	-9.39%	+43.43%	-2.33%	-83.04%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GCTK GlucoTrack	$0.34 -2.4%	$0.39	$0.25 ▼ $14.14	$2.62M	0.7	6.33 million shs	50,984 shs
HSCS HeartSciences	$2.91 +3.8%	$2.39	$1.63 ▼ $3.80	$11.10M	1.79	908,368 shs	263,078 shs
ICCM IceCure Medical	$2.24 -7.9%	$3.90	$2.12 ▼ $42.00	$7.79M	0.47	1.31 million shs	481,421 shs
INBS Intelligent Bio Solutions	$2.35 -6.4%	$2.19	$1.52 ▼ $24.90	$6.95M	4.21	318,799 shs	35,073 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GCTK GlucoTrack	0.00%	-5.44%	+19.30%	-30.52%	-93.72%
HSCS HeartSciences	0.00%	+35.92%	+17.15%	+41.41%	-23.29%
ICCM IceCure Medical	0.00%	-19.54%	-21.10%	-65.53%	-90.82%
INBS Intelligent Bio Solutions	0.00%	-9.39%	+43.43%	-2.33%	-83.04%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GCTK GlucoTrack	1.00	Sell	N/A	N/A
HSCS HeartSciences	2.00	Hold	$8.00	175.39% Upside
ICCM IceCure Medical	2.20	Hold	$52.50	2,244.80% Upside
INBS Intelligent Bio Solutions	1.50	Reduce	N/A	N/A

Current Analyst Ratings Breakdown

Latest GCTK, ICCM, HSCS, and INBS Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/14/2026	ICCM IceCure Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/17/2026	GCTK GlucoTrack	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	ICCM IceCure Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	INBS Intelligent Bio Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/29/2026	INBS Intelligent Bio Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/24/2026	HSCS HeartSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 8/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$2.80 per share	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	$0.07 per share	N/A
ICCM IceCure Medical	$3.38M	2.27	N/A	N/A	$3.72 per share	0.60
INBS Intelligent Bio Solutions	$4.22M	1.69	N/A	N/A	$2.21 per share	1.06

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GCTK GlucoTrack	-$19.39M	-$9.18	N/A	N/A	N/A	N/A	-2,135.52%	-290.22%	N/A
HSCS HeartSciences	-$9.14M	-$3.94	N/A	N/A	N/A	N/A	-358.60%	-144.82%	9/10/2026 (Estimated)
ICCM IceCure Medical	-$15.06M	-$8.52	N/A	N/A	N/A	-427.67%	-174.26%	-112.58%	N/A
INBS Intelligent Bio Solutions	-$12.43M	-$9.02	N/A	N/A	N/A	-294.88%	-175.35%	-91.25%	11/11/2026 (Estimated)

Latest GCTK, ICCM, HSCS, and INBS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/10/2026	Q1 2027	HSCS HeartSciences	-$0.72	N/A	N/A	N/A	$0.10 million	N/A
8/19/2026	Q4 2026	INBS Intelligent Bio Solutions	-$1.58	-$0.90	+$0.68	-$0.90	$1.22 million	$1.15 million
7/23/2026	Q4 2026	HSCS HeartSciences	-$0.66	-$0.88	-$0.22	-$0.87	$0.05 million	N/A
6/30/2026	Q2 2026	ICCM IceCure Medical	N/A	-$1.64	N/A	-$1.6350	N/A	$0.91 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
ICCM IceCure Medical	N/A	N/A	N/A	N/A	N/A
INBS Intelligent Bio Solutions	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GCTK GlucoTrack	0.08	0.46	0.46
HSCS HeartSciences	N/A	0.53	0.40
ICCM IceCure Medical	N/A	2.88	2.44
INBS Intelligent Bio Solutions	N/A	1.44	1.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GCTK GlucoTrack	10.92%
HSCS HeartSciences	17.24%
ICCM IceCure Medical	0.62%
INBS Intelligent Bio Solutions	32.97%

Insider Ownership

Company	Insider Ownership
GCTK GlucoTrack	5.90%
HSCS HeartSciences	4.90%
ICCM IceCure Medical	2.44%
INBS Intelligent Bio Solutions	1.27%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GCTK GlucoTrack	5	7.72 million	7.26 million	Not Optionable
HSCS HeartSciences	10	3.90 million	3.71 million	Not Optionable
ICCM IceCure Medical	60	3.43 million	3.34 million	Not Optionable
INBS Intelligent Bio Solutions	10	3.03 million	2.99 million	Not Optionable

GCTK, ICCM, HSCS, and INBS Headlines

Recent News About These Companies

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

August 19, 2026 | globenewswire.com

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?

August 17, 2026 | benzinga.com

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

August 17, 2026 | globenewswire.com

Intelligent Bio Solutions (INBS) Projected to Announce Earnings on Monday

August 16, 2026 | americanbankingnews.com

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

August 11, 2026 | markets.businessinsider.com

Intelligent Bio Solutions Advances Fingerprint Drug Screening Program

August 6, 2026 | theglobeandmail.com

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

August 5, 2026 | globenewswire.com

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System

August 3, 2026 | globenewswire.com

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

July 23, 2026 | globenewswire.com

Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market

July 21, 2026 | globenewswire.com

INBS Share News Today

July 8, 2026 | uk.investing.com

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

June 16, 2026 | globenewswire.com

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

June 4, 2026 | globenewswire.com

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

June 2, 2026 | globenewswire.com

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

May 13, 2026 | globenewswire.com

Intelligent Bio Solutions Inc. Launches Validation Study to Achieve Sub-3-Minute Results in Roadside Drug Testing Technology

April 20, 2026 | quiverquant.comQ

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

April 20, 2026 | globenewswire.com

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

April 17, 2026 | globenewswire.com

INBS stock falls after clinical study win: FDA progress fails to lift shares

April 2, 2026 | msn.com

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

April 2, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GCTK, ICCM, HSCS, and INBS Company Descriptions

GlucoTrack NASDAQ:GCTK

$0.34 -0.01 (-2.42%)

As of 10:11 AM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

HeartSciences NASDAQ:HSCS

$2.88 +0.09 (+3.04%)

As of 10:12 AM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

IceCure Medical NASDAQ:ICCM

$2.24 -0.19 (-7.82%)

As of 10:12 AM Eastern

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Intelligent Bio Solutions NASDAQ:INBS

$2.35 -0.16 (-6.41%)

As of 10:12 AM Eastern

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GCTK, ICCM, HSCS, and INBS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GCTK, ICCM, HSCS, and INBS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GCTK, ICCM, HSCS, and INBS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GCTK, ICCM, HSCS, and INBS Company Descriptions

GlucoTrack NASDAQ:GCTK

HeartSciences NASDAQ:HSCS

IceCure Medical NASDAQ:ICCM

Intelligent Bio Solutions NASDAQ:INBS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GCTK, ICCM, HSCS, and INBS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GCTK, ICCM, HSCS, and INBS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GCTK, ICCM, HSCS, and INBS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GCTK, ICCM, HSCS, and INBS Company Descriptions

GlucoTrack NASDAQ:GCTK

HeartSciences NASDAQ:HSCS

IceCure Medical NASDAQ:ICCM

Intelligent Bio Solutions NASDAQ:INBS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools